Sign in

CIK 0001894525 · <br>Emerging growth company

Apimeds Pharmaceuticals US, Inc.

Sign in to watch
Ticker
APUS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
851099700
Phone
848-201-5010
Business address
100 MATAWAN RD, SUITE 325, MATAWAN, NJ, 07747
  1. 10-K Report Annual Report
  2. 8-K Event Bylaws or fiscal year change
  3. NT 10-K Other NT 10-K
  4. CERT Other Certification
  5. 8-A12B Other Registration of Securities
  6. EFFECT Other Notice of Effectiveness
  7. FWP Offering Free Writing Prospectus
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. S-1/A Offering Registration Statement
  10. UPLOAD Other SEC-generated Letter
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. S-1/A Offering Registration Statement
  14. S-1/A Offering Registration Statement
  15. S-1/A Offering Registration Statement
  16. S-1/A Offering Registration Statement
  17. CORRESP Other Correspondence Between Filers and SEC Staff
  18. UPLOAD Other SEC-generated Letter
  19. S-1/A Offering Registration Statement
  20. S-1/A Offering Registration Statement

Page 6 of 7 · 130 filings